PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

aclidinium vs mometasone

Side-by-side comparison of aclidinium and mometasone Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
aclidinium Long-Acting Muscarinic Antagonist (LAMA)
mometasone Inhaled Corticosteroid
Type
aclidinium Prescription
mometasone Prescription
Summary
aclidinium

Duaklir Pressair is a combination medicine used to help people with COPD breathe better. It contains two medicines that open up the airways in your lungs.

mometasone

Mometasone cream is a medicine that reduces skin inflammation and itching. It belongs to a class of drugs called corticosteroids.

What It Treats
aclidinium

Duaklir Pressair is used to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open the airways and make it easier to breathe for people with COPD.

mometasone

This cream treats skin problems that cause inflammation and itching. It can be used for skin conditions that respond to corticosteroids. It is for use on people 2 years and older.

How It Works
aclidinium

Duaklir Pressair contains two medicines that work in different ways. One medicine relaxes the muscles around your airways, opening them up. The other medicine prevents the muscles from tightening.

mometasone

Mometasone is a corticosteroid that reduces inflammation. It works by reducing the chemicals in the body that cause swelling and itching. This helps to relieve skin irritation.

Common Side Effects
aclidinium
  • Upper respiratory infection
  • Headache
  • Back pain
mometasone
  • Burning
  • Itching
  • Skin thinning
FAERS Reports
aclidinium
  • Difficulty breathing 1,869
  • Inhaler not working correctly 1,281
  • Skipped a dose of medicine 1,017
  • Asthma 814
  • Chronic obstructive pulmonary disease (COPD) 764
mometasone
  • Difficulty breathing 1,730
  • Asthma 1,553
  • Medicine not working 1,477
  • Headache 1,394
  • Cough 1,178
Serious Warnings
aclidinium

LABAs, such as formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, increase the risk of asthma-related death. Duaklir Pressair is not for asthma. Do not use Duaklir Pressair if you are allergic to milk proteins or any of the ingredients in it. Tell your doctor if you have heart problems, glaucoma, trouble urinating, diabetes, or seizures.

mometasone

Using too much mometasone cream, using it for a long time, or covering large areas of skin can increase the risk of side effects. This can cause your body to stop making enough of its own natural steroid hormones. Children are more likely to get these side effects. This medicine may also increase your risk of cataracts and glaucoma. Tell your doctor if you have blurred vision.

Pregnancy
aclidinium

It is not known if Duaklir Pressair will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if this medicine passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking Duaklir Pressair.

mometasone

If you are pregnant, use mometasone cream only if your doctor says it is okay. There may be risks to the baby. It is not known if mometasone passes into breast milk, so talk to your doctor before using it if you are breastfeeding.

Also Compare — Nearby Drugs

How to Read This aclidinium vs mometasone Comparison

aclidinium is classified in the Long-Acting Muscarinic Antagonist (LAMA) drug class, while mometasone sits within the Inhaled Corticosteroid class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aclidinium has 5,745 submissions while mometasone has 7,332. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aclidinium and mometasone — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.